X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
Enter email and you're done. No subscription, no credit card.
Search, tap and you're done. Over 3,400 medicines.
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Ramipril is the most commonly prescribed blood pressure reducer in Germany — with over 4.7 billion defined daily doses per year. As an ACE inhibitor, it not only lowers blood pressure but also protects the heart and kidneys. But almost everyone affected is familiar with one side effect: the typical dry dry cough.
See more detail.gif)
Ramipril is prescription-only. Never stop it on your own. With sudden swelling of the lips, face, or tongue, call emergency services at once (112; or 999/112 in the UK).
Ramipril is the most prescribed ACE inhibitor in Germany – with over 4.7 billion daily doses per year. That is no surprise: ACE inhibitors not only lower blood pressure, they protect the heart, kidneys, and vessels at the same time. With the HOPE study (2000), ramipril has one of the strongest cardiovascular evidence bases of all blood pressure reducers and is therefore the preferred medication in high-risk prevention.
| Property | Details |
|---|---|
| Active substance | Ramipril (prodrug → active metabolite: ramiprilat) |
| ATC code | C09AA05 (ACE inhibitor, plain) |
| Substance class | ACE inhibitor (angiotensin-converting enzyme inhibitor) |
| Available forms | Tablets (1.25 mg, 2.5 mg, 5 mg, 10 mg) |
| Half-life | Ramipril: about 3 h; ramiprilat (active): 13–17 h |
| Max. daily dose | 10 mg |
| Onset of action | 1–2 hours, full blood pressure reduction after 3–4 weeks |
| Prescription status | Yes – prescription-only |
| Special feature | The most prescribed ACE inhibitor in Germany (>4.7 bn DDD/year) |
Ramipril is – like all ACE inhibitors – a prodrug: after absorption it is converted in the liver into its active metabolite ramiprilat. Ramiprilat blocks the angiotensin-converting enzyme (ACE), which plays a central role in the renin-angiotensin-aldosterone system (RAAS). Simplified: the RAAS is the hormone system that regulates blood pressure and kidney function. When it is overactive, blood pressure rises. Ramipril brakes it.
Concretely, ramiprilat inhibits the conversion of angiotensin I into angiotensin II – one of the strongest vessel-narrowing substances of the body. Less angiotensin II means: wider blood vessels, lower blood pressure, less aldosterone (the kidneys excrete more water and sodium), and a lower burden on the heart.
The HOPE study (2000, Yusuf et al.) is one of the most important milestones of cardiology: in high-risk patients (heart disease, diabetes + risk factor) ramipril reduced heart attack, stroke, and cardiovascular death by 22% – beyond the pure blood pressure effect. Ramipril also prevents the harmful remodelling of the heart muscle after an infarction and with heart failure. Enter all heart medications in your digital medication plan.
For the kidneys: ramipril lowers the pressure in the kidney filters (glomeruli) and reduces the protein excretion in the urine (proteinuria). This makes it the agent of choice with diabetic nephropathy – it demonstrably slows the progression of the kidney disease.
ACE not only converts angiotensin I, it also inactivates bradykinin. On ramipril the bradykinin level rises. This is two-edged: more bradykinin widens the vessels (positive, strengthens the blood pressure effect) and has anti-inflammatory effects (positive). But: bradykinin also irritates the bronchial mucosa – this explains the typical ACE inhibitor dry cough, which affects up to 20% of patients.
The most important rule with ramipril: never start with the target dose. ACE inhibitors can cause a pronounced blood pressure drop at the start of therapy – particularly in patients who take diuretics at the same time, with heart failure, or with dehydration. Therefore there is always a gradual up-titration: a low starting dose, increasing every 2–4 weeks.
| Indication | Starting dose | Target dose | Increase |
|---|---|---|---|
| High blood pressure | 1.25–2.5 mg/day | 2.5–10 mg/day | Doubling every 2–4 weeks |
| Heart failure | 1.25 mg/day | 10 mg/day (2× 5 mg) | Doubling every 1–2 weeks |
| After heart attack | 2.5 mg 2×/day | 5 mg 2×/day | Increase after 2 days |
| Kidney protection (nephropathy) | 1.25 mg/day | 5 mg/day | Increase slowly |
| Cardiovascular prevention | 2.5 mg/day | 10 mg/day | Increase every 1–3 weeks |
| GFR (ml/min) | Max. daily dose | Note |
|---|---|---|
| ≥ 60 | 10 mg | No restriction |
| 30–59 | 5 mg | Check kidney values + potassium regularly |
| <30 | 2.5 mg | Close monitoring, starting dose 1.25 mg |
Ramipril can be taken independently of meals – food does not influence the absorption. The intake time is flexible: the morning is standard, but with raised night-time blood pressure the doctor can recommend an evening intake. Newer studies (TIME study 2022) show that the intake time is, overall, less decisive than the daily regularity.
The ACE inhibitor dry cough affects up to 20% of patients – and is the most common cause of a therapy discontinuation. It is dry, persistent, non-productive, and can occur shortly after the start of therapy or only months later. The cause: as explained above, the bradykinin level rises on ramipril. Bradykinin irritates the bronchial mucosa chemically – this is why cough suppressants or cold remedies do not help.
The only effective solution: a switch to a sartan (candesartan, valsartan, and others). Sartans block the angiotensin II receptor directly, do not intervene in the bradykinin metabolism, and therefore do not cause a cough. The blood pressure reduction and the organ protection are comparable. Anyone who suffers from a dry cough: speak to the doctor – do not suffer for months.
| Side effect | Frequency | What to do? |
|---|---|---|
| Dry cough | Common (up to 20%) | Inform the doctor, a switch to a sartan if needed |
| Dizziness / blood pressure drop | Common | Above all at the start of therapy; stand up slowly |
| Headaches, fatigue | Common | Often improves after 1–2 weeks |
| Hyperkalaemia (raised potassium) | Common | Check the potassium level regularly |
| Rash, itching | Occasional | Inform the doctor |
| Taste disturbances (metallic) | Occasional | Mostly temporary |
| Kidney function disturbance | Occasional | Check kidney values + potassium |
| Angio-oedema (swelling face/throat) | Rare (0.1–0.2%) | EMERGENCY – call emergency services at once (112; or 999/112 in the UK), stop ramipril! |
Ramipril has some clinically significant interactions. By far the most common in German everyday practice: the combination with NSAIDs – often unwittingly, because patients reach for over-the-counter ibuprofen without asking. Check all combinations in the interaction check.
Known in nephrology as the "Triple Whammy": the simultaneous intake of an ACE inhibitor (ramipril) + an NSAID (ibuprofen) + a diuretic (e.g. HCT or furosemide). Each of these three medications alone impairs kidney function moderately. All three together can trigger an acute kidney failure – even with previously normal kidney values. This combination occurs frequently in everyday life, because patients buy ibuprofen over the counter without knowing that they take an ACE inhibitor and a diuretic.
| Substance / medication | Interaction | Recommendation |
|---|---|---|
| Ibuprofen / diclofenac (NSAIDs) | Weakens the blood pressure reduction + raises the kidney damage risk | Prefer paracetamol! With short-term NSAIDs: check kidney values |
| Potassium preparations / potassium-rich diet | Ramipril raises potassium – additional potassium can lead to hyperkalaemia | No additional potassium without medical control |
| Potassium-sparing diuretics (spironolactone) | Strongly increased hyperkalaemia risk | Only under close potassium control |
| Lithium | Ramipril reduces lithium excretion → the level rises | Check the lithium level more frequently |
| Sacubitril/valsartan (Entresto) | Increased angio-oedema risk | At least 36 hours apart! |
| Aliskiren | Double RAAS blockade – hyperkalaemia, kidney damage | Contraindicated with diabetes or GFR <60 |
| Metformin | Ramipril can lower blood sugar slightly | Check blood sugar more frequently at the start of therapy |
| Alcohol | Enhances the blood-pressure-lowering effect | Limit, particularly at the start of therapy |
